Chronic lymphocytic leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
The term "chronic" in chronic lymphocytic leukemia comes from the fact that it typically progresses more slowly than other types of leukemia. The term "lymphocytic" in chronic lymphocytic leukemia comes from the cells affected by the disease — a group of white blood cells called lymphocytes, which help your body fight infection.
Chronic lymphocytic leukemia most commonly affects older adults. There are treatments to help control the disease.
The Chronic Lymphoproliferative Disorders Group at Mayo Clinic evaluates and treats patients with excess blood lymphocytes and disorders of the lymph nodes and spleen, including those diagnosed with:
- Chronic lymphocytic leukemia
- Hairy cell leukemia
- Large granular lymphocyte disorders
- Natural killer cell leukemia
- Prolymphocytic leukemia
- Chronic Lymphocytic Leukemia (CLL)
- CLL: What is 'watch & wait' and what can a patient do during this phase?
- Large granular lymphocytic leukemia
- Malignant Fibrous Histiocytoma in CLL and Non-Hodgkin Lymphoma
- New Treatments for Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia (CLL): Changes in frontline treatment